Page Banner
QuantiFERON®-TB Gold (QFT)


QuantiFERON®-TB Gold (QFT) is a simple blood test that aids in the detection of Mycobacterium tuberculosis, the bacteria which causes tuberculosis (TB). QFT is an interferon gamma release assay, commonly known as an IGRA, and is a modern alternative to the tuberculin skin test (TST). Unlike the TST, QFT is a controlled laboratory test that requires only one patient visit and works on patients who have previously been vaccinated against TB with the Bacille Calmette-Guerin (BCG) vaccination.

How is the test performed?

A simple blood test

Email me a screening package




QFT is a highly accurate, single visit IGRA test for screening potentially TB-infected patients and accurately diagnosing Latent TB Infections (LTBI).


Healthcare provider needs to indicate ‘QFT’ in the ‘Other Tests’ section of the requisition form.

Patient Instructions

Patient needs to bring the completed requisition form to a Patient Service Centre.



Test results will be available within 2 weeks.


This test is not currently covered by provincial health plans, but may be covered by the patient’s private insurance.

QFT accurately diagnoses Latent TB Infections (LTBI) which is an asymptomatic infection and is believed to affect over one-quarter of the global population. Approximately 5-15% of infected individuals will progress to active TBI if not diagnosed and treated. This progression is called the reactivation of LTBI.

QFT measures the amount of interferon gamma that is released when infected white blood cells in a blood sample come into contact with specific antigens of M. tuberculosis. The use of whole blood in QFT makes T cell incubation simple and fast, and reduces turn-around time (TAT). It is simple as there is no lymphocyte isolation, washing, counting, diluting, or culturing.

The QFT Test can be used be used for individuals who’ve had contact with individuals diagnosed with active pulmonary TB, are at increased risk of progression to active TB disease due to impaired immunity, have radiographic evidence of old, healed TB without history of treatment and have an increased risk for LTBI due to injection-drug use. Additionally, the following individuals should be screened for tuberculosis:

  • Foreign-born persons and visitors from TB-endemic countries, especially immigrants who have arrived in the last two years
  • Residents and employees of prisons and jails
  • Individuals eligible for LTBI surveillance programs such as health-care workers, aid workers and military personnel

QFT works on patients who have previously been vaccinated against TB with the Bacille Calmette-Guerin (BCG) vaccination. QFT requires only one patient visit, has a low (1%) false-positive rate and high specificity (>99%) which reduces unnecessary evaluations (labs, X-rays).

The blood sample is collected in three specialized tubes (NIL, TB Antigen and Mitogen) that enable immediate exposure of the white blood cells to highly specific TB antigens. The QFT results are reported qualitatively as negative or positive for the bacteria, as well as quantitatively with a numerical value (reported in IU/mL). The numerical value indicates the amount of interferon gamma that is released when infected blood cells are exposed to specific antigens of M.tuberculosis.

For a test to be considered positive, the TB Antigen tube value minus the NIL tube value must be greater than or equal to 0.35 IU/mL.

QFT is a blood test that is collected in three sample tubes that allow for control-based testing in a laboratory environment. An immune response is observed when antigen from M. tuberculosis comes into contact with infected white blood cells. The test is simple, fast and considered the most clinically tested and proven. QFT can accurately diagnose LTBI, which is a state of persistent immune response which evidence of clinically active TB.

QFT is usually ordered to detect LTBI in the following conditions:  

  • Individuals who’ve had contact with persons recently diagnosed with active TB
  • Foreign-born persons and visitors from TB prone countries, especially immigrants who have arrived in the last two years
  • People who are at increased risk of progression to active TB disease due to impaired immunity
  • People with evidence of old, healed TB without history of treatment
  • People with an increased risk for LTBI due to injection-drug use, and residents and employees of prisons and jails
  • Persons who are, by history, at low risk for LTBI but whose future activity might place them at increased risk for exposure, and others eligible for LTBI surveillance programs (e.g., health-care workers, aid workers and military personnel)

The current fee for this test is C$95.00. It is not covered by the provincial health insurance plans, but it may be covered by extended health insurance plans.

The QFT test is available in select LifeLabs locations in Ontario; please refer to the table below for more details.

Your doctor will receive the results between 5 to 10 business days of the blood test.

1. Qiagen, QuantiFERON®–TB Gold product information
2. Pai et. al. Canadian Tuberculosis Standards 7th Edition: 2014 – Diagnosis of latent Tuberculosis infection
3. Centers for Disease Control and Prevention, Guidelines for Using the QuantiFERON®-TB Test for Diagnosing Latent Mycobacterium tuberculosis Infection, 2012
4. CDC. Updated guidelines for using gamma release assays to detect m. tuberculosis infection. MMWR. 2010;59(RR05):1-25
5. City of Toronto, Tuberculosis Information for Healthcare Providers: Management of Latent Tuberculosis Infection and Active Disease – Information for Health Professionals
6. Latent tuberculosis infection: An overview – CCDR: Volume 43-3/4, March 2, 2017: Tuberculosis (TB)
7. World Health Organization’s Fact Sheet on Tuberculosis

People who looked at the QUANTIFERON-TB GOLD were also interested in:

Helping Naturopathic Doctors Gain a Better View of the Health Status of their Patients

Patient Assessment Panels

Patient Assessment Panels enable you to provide your Naturopathic Doctor with a complete picture of your health. Now you can access the blood work required to make informed decisions on how to be your healthiest you!
1. Convenient
2. Comprehensive
3. Cost-effective
Personalized Risk Assessment of Prostate Cancer

SelectMDx Testing

Learning you have elevated PSA can be alarming news, but elevated PSA does not mean you have clinically significant disease and require a biopsy or treatment. SelectMDx is a novel decision support tool and provides your urologist with additional important information on the likelihood of finding aggressive cancer upon biopsy.
Fecal Calprotectin Testing

Differentiating Between

Canada has one of the highest incidence and prevalence rates of inflammatory bowel disease and irritable bowel syndrome in the world. With symptoms of these two conditions appearing similar, Fecal Calprotectin testing can provide an accurate diagnosis in many patients with chronic diarrhea without the need of doing invasive diagnostic procedures.
Know Your Risk for Heart Attacks

PULS (Protein Unstable Lesion Signature Test)

The second leading cause of death among Canadians, heart attacks are often a silent killer with no signs or symptoms before they strike. Often resulting from coronary heart disease, heart attacks can be predicted and even prevented if you know and manage your risk.
Early Detection of Prostate Cancer

Prostate-Specific Antigen (PSA) Test

One in seven men in Canada will be diagnosed with prostate cancer in their lifetime. The third leading cause of cancer death, when prostate cancer is detected early, the more likely it can be successfully treated.
Determine your risk of bone fractures


Known as the “silent thief”, osteoporosis is responsible for the loss of bone mass without obvious symptoms until a bone is broken. By knowing your risk through a Serum CTX Test, you can prevent, delay or reduce bone loss.
Detecting Rheumatoid Arthritis


When your immune system attacks your joints, the daily pain, stiffness and swelling can go undiagnosed for months causing permanent damage. Quickly and accurately diagnosing rheumatoid arthritis can prevent damage and improve long-term quality of life.
Early Detection of Cervical Cancer

HPV Testing

About 75% of sexually active women will get a least one HPV infection in their lifetime. With HPV the primary cause of cervical cancer, the HPV test detects the presence of high-risk HPV strain(s).
Diagnosing Celiac Disease

Celiac Disease

Celiac disease can arise at any age creating damage to your intestines and starving your body of critical nutrients. With a range of symptoms commonly associated with other conditions, knowing if you are celiac, or simply have a gluten allergy or intolerance, is key to ensuring you’re on the right path to health.
Detecting Rheumatoid Arthritis


The daily pain, stiffness and swelling of rheumatoid arthritis can go undiagnosed for months causing permanent damage to your body. Diagnosing rheumatoid arthritis at its earliest stages can prevent damage and improve long-term quality of life.
Fertility Test

Anti-Müllerian Hormone (AMH)

With one in six couples across Canada experiencing difficulty in becoming pregnant, AMH levels can provide valuable insight into predicting a response for IVF treatment.
Vitamin Levels

25-Hydroxy Vitamin D Test

Vitamin D helps your body absorb calcium and phosphorus and is essential
for proper growth and healthy teeth and bones throughout your life.
Page Banner

LifeLabs Comes to You!


Only $60 for up to three people of your choice serviced at the same location and appointment time.

Services offered

Blood tests, ECG monitoring, Holter monitoring


Now serving all of Toronto and, select areas in York, Peel and Halton regions, Newmarket and more!